Skip to Main Content

Paper Details

Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series.
Lancet Gastroenterol Hepatol
53
2018
Author NameAffiliation
Carme CampsNational Institute for Health Research Oxford Biomedical Research Centre
Robyn L WardUniversity of Queensland
Robyn L WardUniversity of Queensland
Nicholas J HawkinsUniversity of Queensland
Nicholas J HawkinsUniversity of Queensland
Claire Palles
Jenny C TaylorNational Institute for Health Research Oxford Biomedical Research Centre
  • 1 - 7

Datasets

Release 1.2